F-14/15, Orbit Mall, Civil Lines, Jaipur-302006
support@thetaxheaven.com
F-14/15, Orbit Mall, Civil Lines, Jaipur-302006 support@thetaxheaven.comJohnson Pharmacare Ltd, a key player in the pharmaceutical industry, has been drawing investor attention due to its steady market presence and affordable share price. Despite being a low-value stock, it has shown resilience and potential for future growth. With a 52-week high of ₹1.44 and a low of ₹0.68, the stock has witnessed volatility, influenced by investor sentiment and market trends.
As retail investors hold 100% of the company’s shares, speculative trading significantly impacts its price movements. This makes it essential for investors to analyze key financial metrics, market trends, and future growth prospects before making an informed decision.
In this article, we will examine the current market performance of Johnson Pharmacare Ltd, its shareholding pattern, and an in-depth analysis of its projected share price targets from 2025 to 2030.
Let's begin by analyzing the latest market performance of Johnson Pharmacare Ltd:
Open Price: ₹1.04
Previous Close: ₹1.04
Volume: 1,195,862 shares
Value (Lacs): ₹12.56
VWAP (Volume Weighted Average Price): ₹1.04
Beta: 0.40
Market Capitalization: ₹57 Crore
High: ₹1.06
Low: ₹1.04
Upper Circuit Limit: ₹1.24
Lower Circuit Limit: ₹0.84
52-Week High: ₹1.44
52-Week Low: ₹0.68
Face Value: ₹1
All-Time High: ₹210.18
All-Time Low: ₹0.36
20-Day Average Volume: 2,777,477 shares
20-Day Average Delivery Percentage: 36.32%
Book Value Per Share: ₹1.03
As of now, Johnson Pharmacare Ltd's stock price remains stable at ₹1.04, showing limited fluctuations. With a 52-week high of ₹1.44 and a low of ₹0.68, the stock has witnessed volatility due to market trends and investor sentiment.
Retail & Others: 100.00%
Since the entire shareholding is in the hands of retail investors, the stock might experience higher volatility due to speculative trading.
Considering the current market scenario, financials, and future growth potential, here are the projected share price targets for Johnson Pharmacare Ltd from 2025 to 2030:
| Year | Share Price Target (₹) |
|---|---|
| 2025 | 1.04 – 1.24 |
| 2026 | 1.24 – 1.50 |
| 2027 | 1.50 – 1.80 |
| 2028 | 1.80 – 2.20 |
| 2029 | 2.20 – 2.80 |
| 2030 | 2.80 – 3.50 |
The stock is expected to trade between ₹1.04 and ₹1.24 in 2025. Growth factors include:
Stability in pharmaceutical demand.
Strategic expansions or mergers in the sector.
Speculative trading by retail investors.
By 2026, the stock price is projected to range from ₹1.24 to ₹1.50 due to:
Increased sales from new product launches.
Government incentives in the pharmaceutical industry.
Improved financials and revenue growth.
A gradual rise is expected with price projections between ₹1.50 and ₹1.80, driven by:
Enhanced brand presence in the pharmaceutical sector.
Expansion of market share and customer base.
Potential partnerships with larger firms.
The stock is forecasted to trade between ₹1.80 and ₹2.20 in 2028 due to:
Increased production capacity.
Technological advancements in drug formulation.
Expansion into new geographical markets.
The company may witness further growth, leading to a stock price between ₹2.20 and ₹2.80. Contributing factors include:
Stronger financial performance.
Increased investments in research and development.
Higher institutional investor interest.
By 2030, Johnson Pharmacare Ltd could reach between ₹2.80 and ₹3.50, driven by:
Sustained revenue growth.
Long-term government contracts and exports.
Continuous innovation and diversification of products.
Several factors will impact the company’s future stock price:
Market Sentiment: Retail-driven stocks can be highly volatile due to speculative trading.
Regulatory Approvals: Changes in drug regulations or new product approvals can boost investor confidence.
Financial Performance: Increasing revenue, profit margins, and reducing liabilities will positively impact share prices.
Competition: Growth depends on how well Johnson Pharmacare Ltd competes against larger pharmaceutical companies.
Macroeconomic Factors: Inflation, currency fluctuations, and government policies will play a significant role in stock price movements.
Despite its potential, there are risks that investors should be aware of:
Market Volatility: Since the shareholding pattern is entirely retail-based, the stock may experience unpredictable price swings.
Regulatory Hurdles: Stricter drug approval norms can delay product launches and impact revenue.
Financial Stability: Weak balance sheets or lower profit margins could affect stock performance.
Competitive Pressure: Larger pharmaceutical companies may impact growth prospects.
The stock is expected to range between ₹1.04 and ₹1.24 in 2025, considering current market trends and stability in operations.
With 100% retail investors, the stock might be more volatile, as it is influenced by speculative trading.
The stock has potential, but investors should consider risks such as market volatility, financial performance, and regulatory challenges before investing.
Johnson Pharmacare Ltd is an emerging player in the pharmaceutical industry with significant potential for growth. While the stock is currently trading at a low value, projected price targets indicate gradual appreciation by 2030. However, investors should conduct thorough research and consider market risks before making investment decisions.
Register & Login